Eisai Company, Ltd. (ESALY.PK)'s Cancer Drug Reverses Alzheimer's Symptoms

2/10/2012 7:08:30 AM

In what is seen as a major breakthrough in finding a cure for Alzheimer's, neuroscientists at Case Western Reserve University School of Medicine, Ohio, have found that the use of a cancer drug quickly reversed Alzheimer's symptoms in mice in a study. The drug - Bexarotene, marketed in the United States by Eisai Inc. under the brand name Targretin, is already approved by the FDA for the treatment of cutaneous T-cell lymphoma, or CTCL skin cancer. Alzheimer's disease is characterized by a buildup of toxic amyloid beta peptide and amyloid plaques, which causes changes or deterioration in certain areas of the brain that control thinking, communication, and behavior.

Read at Nasdaq

Read at Bloomberg

Read at Wall Street Journal

Read at AFP

Read at Fox News

Read Article at

Related Companies

News Categories

• Nasdaq

• Bloomberg

• Wall Street Journal

• AFP